Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct 6;8(4):e35310.
doi: 10.2196/35310.

COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study

Nimish Valvi #  1 , Hetvee Patel  2 , Giorgos Bakoyannis  2 , David A Haggstrom  3   4   5 , Sanjay Mohanty  4 , Brian E Dixon #  1   2   3
Affiliations

COVID-19 Diagnosis and Risk of Death Among Adults With Cancer in Indiana: Retrospective Cohort Study

Nimish Valvi et al. JMIR Cancer. .

Abstract

Background: Prior studies, generally conducted at single centers with small sample sizes, found that individuals with cancer experience more severe outcomes due to COVID-19, caused by SARS-CoV-2 infection. Although early examinations revealed greater risk of severe outcomes for patients with cancer, the magnitude of the increased risk remains unclear. Furthermore, prior studies were not typically performed using population-level data, especially those in the United States. Given robust prevention measures (eg, vaccines) are available for populations, examining the increased risk of patients with cancer due to SARS-CoV-2 infection using robust population-level analyses of electronic medical records is warranted.

Objective: The aim of this paper is to evaluate the association between SARS-CoV-2 infection and all-cause mortality among recently diagnosed adults with cancer.

Methods: We conducted a retrospective cohort study of newly diagnosed adults with cancer between January 1, 2019, and December 31, 2020, using electronic health records linked to a statewide SARS-CoV-2 testing database. The primary outcome was all-cause mortality. We used the Kaplan-Meier estimator to estimate survival during the COVID-19 period (January 15, 2020, to December 31, 2020). We further modeled SARS-CoV-2 infection as a time-dependent exposure (immortal time bias) in a multivariable Cox proportional hazards model adjusting for clinical and demographic variables to estimate the hazard ratios (HRs) among newly diagnosed adults with cancer. Sensitivity analyses were conducted using the above methods among individuals with cancer-staging information.

Results: During the study period, 41,924 adults were identified with newly diagnosed cancer, of which 2894 (6.9%) tested positive for SARS-CoV-2. The population consisted of White (n=32,867, 78.4%), Black (n=2671, 6.4%), Hispanic (n=832, 2.0%), and other (n=5554, 13.2%) racial backgrounds, with both male (n=21,354, 50.9%) and female (n=20,570, 49.1%) individuals. In the COVID-19 period analysis, after adjusting for age, sex, race or ethnicity, comorbidities, cancer type, and region, the risk of death increased by 91% (adjusted HR 1.91; 95% CI 1.76-2.09) compared to the pre-COVID-19 period (January 1, 2019, to January 14, 2020) after adjusting for other covariates. In the adjusted time-dependent analysis, SARS-CoV-2 infection was associated with an increase in all-cause mortality (adjusted HR 6.91; 95% CI 6.06-7.89). Mortality increased 2.5 times among adults aged 65 years and older (adjusted HR 2.74; 95% CI 2.26-3.31) compared to adults 18-44 years old, among male (adjusted HR 1.23; 95% CI 1.14-1.32) compared to female individuals, and those with ≥2 chronic conditions (adjusted HR 2.12; 95% CI 1.94-2.31) compared to those with no comorbidities. Risk of mortality was 9% higher in the rural population (adjusted HR 1.09; 95% CI 1.01-1.18) compared to adult urban residents.

Conclusions: The findings highlight increased risk of death is associated with SARS-CoV-2 infection among patients with a recent diagnosis of cancer. Elevated risk underscores the importance of adhering to social distancing, mask adherence, vaccination, and regular testing among the adult cancer population.

Keywords: COVID-19; Cox proportional hazards model; EHR; Kaplan-Meier; SARS-CoV-2; cancer; cancer experience; cancer population; coronavirus; death; electronic health record; hazard ratio; mortality; oncology; outcome; patient with cancer; risk; survival.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: None declared.

Figures

Figure 1
Figure 1
Kaplan-Meier survival estimates of overall cancer population by age group (years), Indiana, 2019-2020.
Figure 2
Figure 2
Kaplan-Meier survival estimates of overall cancer population by sex, Indiana, 2019-2020.
Figure 3
Figure 3
Kaplan-Meier survival estimates of overall cancer population by race and ethnicity, Indiana, 2019-2020.
Figure 4
Figure 4
Kaplan-Meier survival estimates of overall cancer population by number of comorbidities, Indiana, 2019-2020.
Figure 5
Figure 5
Kaplan-Meier survival estimates of overall cancer population by SARS-CoV-2 diagnosis, Indiana, 2019-2020.
See this image and copyright information in PMC

References

    1. COVID-19 dashboard. Center for Systems Science and Engineering (CSSE) [2021-07-15]. https://coronavirus.jhu.edu/map.html .
    1. Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19) World Health Organization. [2022-09-29]. https://bit.ly/3E1NrPt .
    1. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 Mar;21(3):335–337. doi: 10.1016/S1470-2045(20)30096-6. https://europepmc.org/abstract/MED/32066541 S1470-2045(20)30096-6 - DOI - PMC - PubMed
    1. Miyashita H, Mikami T, Chopra N, Yamada T, Chernyavsky S, Rizk D, Cruz C. Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City. Ann Oncol. 2020 Aug;31(8):1088–1089. doi: 10.1016/j.annonc.2020.04.006. https://linkinghub.elsevier.com/retrieve/pii/S0923-7534(20)39303-0 S0923-7534(20)39303-0 - DOI - PMC - PubMed
    1. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA Oncol. 2020 Jul 01;6(7):1108–1110. doi: 10.1001/jamaoncol.2020.0980. https://europepmc.org/abstract/MED/32211820 2763673 - DOI - PMC - PubMed